William A. Gahl

ORCID: 0000-0002-2494-6752
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Biomedical Research and Pathophysiology
  • melanin and skin pigmentation
  • Neonatal Health and Biochemistry
  • Genomics and Rare Diseases
  • Amino Acid Enzymes and Metabolism
  • Metabolism and Genetic Disorders
  • Genetics and Neurodevelopmental Disorders
  • Genetic and Kidney Cyst Diseases
  • Glycosylation and Glycoproteins Research
  • RNA regulation and disease
  • Biochemical Analysis and Sensing Techniques
  • Lysosomal Storage Disorders Research
  • Genomic variations and chromosomal abnormalities
  • Inflammatory Myopathies and Dermatomyositis
  • Cellular transport and secretion
  • Mitochondrial Function and Pathology
  • RNA modifications and cancer
  • Neurogenetic and Muscular Disorders Research
  • Histiocytic Disorders and Treatments
  • RNA Research and Splicing
  • Autoimmune and Inflammatory Disorders Research
  • Cell Adhesion Molecules Research
  • Folate and B Vitamins Research
  • Erythrocyte Function and Pathophysiology
  • Methemoglobinemia and Tumor Lysis Syndrome

National Human Genome Research Institute
2016-2025

National Institutes of Health
2016-2025

Office of the Director
2007-2025

Office of the Director
2015-2024

NIH Common Fund
2013-2023

Rady Children's Hospital-San Diego
2023

University of Wisconsin–Madison
1976-2022

University of California System
2022

Office of Extramural Research
2022

Foundation for Ichthyosis and Related Skin Types
2013-2022

Adult-onset inflammatory syndromes often manifest with overlapping clinical features. Variants in ubiquitin-related genes, previously implicated autoinflammatory disease, may define new disorders.We analyzed peripheral-blood exome sequence data independent of phenotype and inheritance pattern to identify deleterious mutations genes. Sanger sequencing, immunoblotting, immunohistochemical testing, flow cytometry, transcriptome cytokine profiling were performed. CRISPR-Cas9-edited zebrafish...

10.1056/nejmoa2026834 article EN New England Journal of Medicine 2020-10-27

Hutchinson–Gilford progeria syndrome is a rare, sporadic, autosomal dominant that involves premature aging, generally leading to death at approximately 13 years of age due myocardial infarction or stroke. The genetic basis most cases this change from glycine GGC GGT in codon 608 the lamin A (LMNA) gene, which activates cryptic splice donor site produce abnormal A; disrupts nuclear membrane and alters transcription.

10.1056/nejmoa0706898 article EN New England Journal of Medicine 2008-02-06

Alkaptonuria, caused by mutations in the HGO gene and a deficiency of homogentisate 1,2-dioxygenase, results an accumulation homogentisic acid (HGA), ochronosis, destruction connective tissue. There is no effective therapy for this disorder, although nitisinone inhibits enzyme that produces HGA. We performed study to delineate natural history alkaptonuria.

10.1056/nejmoa021736 article EN New England Journal of Medicine 2002-12-25

Five children from two consanguineous families presented with epilepsy beginning in infancy and severe ataxia, moderate sensorineural deafness, a renal salt-losing tubulopathy normotensive hypokalemic metabolic alkalosis. We investigated the genetic basis of this autosomal recessive disease, which we call EAST syndrome (the presence epilepsy, tubulopathy).

10.1056/nejmoa0810276 article EN New England Journal of Medicine 2009-05-06

Histiocytic neoplasms are clonal, hematopoietic disorders characterized by an accumulation of abnormal, monocyte-derived dendritic cells or macrophages in Langerhans cell histiocytosis (LCH) and non-Langerhans (non-LCH), respectively. The discovery BRAF(V600E) mutations approximately 50% these patients provided the first molecular therapeutic target histiocytosis. However, recurrent driving majority with BRAF(V600E)-wild-type non-LCH unknown, cooperating non-MAP kinase pathways undefined for...

10.1158/2159-8290.cd-15-0913 article EN Cancer Discovery 2015-11-14

Many patients remain without a diagnosis despite extensive medical evaluation. The Undiagnosed Diseases Network (UDN) was established to apply multidisciplinary model in the evaluation of most challenging cases and identify biologic characteristics newly discovered diseases. UDN, which is funded by National Institutes Health, formed 2014 as network seven clinical sites, two sequencing cores, coordinating center. Later, central biorepository, metabolomics core, organisms screening center were added.

10.1056/nejmoa1714458 article EN New England Journal of Medicine 2018-10-10

10.1111/j.1538-7836.2007.02690.x article EN publisher-specific-oa Journal of Thrombosis and Haemostasis 2007-08-18

PurposeThis report describes the National Institutes of Health Undiagnosed Diseases Program, details Program’s application genomic technology to establish diagnoses, and success rate during its first 2 years.MethodsEach accepted study participant was extensively phenotyped. A subset participants selected family members (29 patients 78 unaffected members) subjected an integrated set analyses including high-density single-nucleotide polymorphism arrays whole exome or genome analysis.ResultsOf...

10.1038/gim.0b013e318232a005 article EN publisher-specific-oa Genetics in Medicine 2012-01-01

Objective Early-onset epileptic encephalopathies have been associated with de novo mutations of numerous ion channel genes. We employed techniques modern translational medicine to identify a disease-causing mutation, analyze its altered behavior, and screen for therapeutic compounds treat the proband. Methods Three tools were utilized: (1) high-throughput sequencing technology novel mutation; (2) in vitro expression electrophysiology assays confirm variant protein's dysfunction; (3)...

10.1002/acn3.39 article EN cc-by-nc-nd Annals of Clinical and Translational Neurology 2014-03-01

Erdheim-Chester Disease (ECD) is a rare, potentially fatal, multi-organ myeloid neoplasm occurring mainly in adults. The diagnosis established by clinical, radiologic, and histologic findings; ECD tumors contain foamy macrophages that are CD68+, CD163+, CD1a-, frequently S100-. purpose of this report to describe the clinical molecular variability ECD. Sixty consecutive patients (45 males, 15 females) were prospectively evaluated at NIH Clinical Center between 2011 2015. Comprehensive imaging...

10.1182/bloodadvances.2016001784 article EN cc-by-nc-nd Blood Advances 2017-02-09
Julia Wang Rami Al‐Ouran Yanhui Hu Seon‐Young Kim Ying‐Wooi Wan and 95 more Michael F. Wangler Shinya Yamamoto Hsiao‐Tuan Chao Aram Comjean Stephanie E. Mohr Norbert Perrimon Zhandong Liu Hugo J. Bellen David R. Adams David R. Adams Mercedes E. Alejandro Patrick Allard Euan A. Ashley Mahshid S. Azamian Carlos A. Bacino Ashok Balasubramanyam Hayk Barseghyan Alan H. Beggs Hugo J. Bellen Jonathan A. Bernstein Anna Bican David Bick Camille L. Birch Braden Boone Lauren C. Briere Donna M. Brown Matthew Brush Elizabeth A. Burke Lindsay C. Burrage Katherine R. Chao Gary Clark Joy D. Cogan Cynthia M. Cooper William J. Craigen Mariska Davids Jyoti G. Dayal Esteban C. Dell’Angelica Shweta U. Dhar Katrina M. Dipple Laurel A. Donnell‐Fink Naghmeh Dorrani Daniel C. Dorset David D. Draper Annika M. Dries David J. Eckstein Lisa Emrick Christine M. Eng Cecilia Esteves Tyra Estwick Paul G. Fisher Trevor S. Frisby Kate Frost William A. Gahl Valerie Gartner Rena A. Godfrey Mitchell Goheen Gretchen Golas David Goldstein Mary “Gracie” G. Gordon Sarah E. Gould Jean-Philippe F. Gourdine Brett H. Graham Catherine Groden Andrea Gropman Mary E. Hackbarth Melissa Haendel Rizwan Hamid Neil A. Hanchard Lori H. Handley Isabel Hardee Matthew Herzog Ingrid A. Holm Ellen M. Howerton Howard J. Jacob Mahim Jain Yong‐hui Jiang Jean M. Johnston Angela Jones Alanna E. Koehler David M. Koeller Isaac S. Kohane Jennefer N. Kohler Donna M. Krasnewich Elizabeth L. Krieg Joel B. Krier Jennifer Kyle Seema R. Lalani Lea Latham Yvonne L. Latour C. Christopher Lau Jozef Lazar Brendan Lee Hane Lee Paul R. Lee Shawn Levy

10.1016/j.ajhg.2017.04.010 article EN publisher-specific-oa The American Journal of Human Genetics 2017-05-11
Victoria E. Rael Julian A. Yano John Huizar Leianna C. Slayden Madeleine A. Weiss and 95 more Elizabeth A. Turcotte J M Terry Wenqi Zuo Isabelle Thiffault Tomi Pastinen Emily Farrow Janda Jenkins Mara L. Becker Stephen C. Wong Anne M. Stevens Catherine Otten Eric J. Allenspach Devon Bonner Jonathan A. Bernstein Matthew T. Wheeler Robert A. Saxton Maria T. Acosta David R. Adams Raquel L. Alvarez Justin Alvey Aimee Allworth Ashley Andrews Euan A. Ashley Ben Afzali Carlos A. Bacino Güney Bademci Ashok Balasubramanyam Dustin Baldridge Jim Bale Michael J. Bamshad Deborah Barbouth Pınar Bayrak‐Toydemir Anita Beck Alan H. Beggs Edward M. Behrens Gill Bejerano Hugo J. Bellen Jimmy Bennett Jonathan A. Bernstein Gerard T. Berry Anna Bican Stephanie Bivona Elizabeth Blue John Bohnsack Devon Bonner Lorenzo D. Botto Lauren C. Briere Gabrielle Brown Elizabeth A. Burke Lindsay C. Burrage Manish J. Butte Peter H. Byers William E. Byrd John M. Carey Thomas Cassini Sirisak Chanprasert Hsiao‐Tuan Chao Iván K. Chinn Gary Clark Terra R. Coakley Laurel A. Cobban Joy D. Cogan Matthew Coggins F. Sessions Cole Heather A. Colley Rosario I. Corona William J. Craigen Andrew B. Crouse Michael L. Cunningham Precilla D’Souza Hongzheng Dai Surendra Dasari Joie Davis Jyoti G. Dayal Margaret Delgado Esteban C. Dell’Angelica Katrina M. Dipple Daniel Doherty Naghmeh Dorrani Argenia L. Doss Emilie D. Douine Dawn Earl David J. Eckstein Lisa Emrick Christine M. Eng Marni J. Falk Elizabeth L. Fieg Paul G. Fisher Brent L. Fogel Jiayu Fu William A. Gahl I. S. Glass Pagé C. Goddard Rena A. Godfrey Andrea Gropman

Nucleic acid-sensing Toll-like receptors (TLR) 3, 7/8, and 9 are key innate immune sensors whose activities must be tightly regulated to prevent systemic autoimmune or autoinflammatory disease virus-associated immunopathology. Here, we report a systematic scanning-alanine mutagenesis screen of all cytosolic luminal residues the TLR chaperone protein UNC93B1, which identified both negative positive regulatory regions affecting TLR3, TLR7, TLR9 responses. We subsequently two families harboring...

10.1084/jem.20232005 article EN cc-by The Journal of Experimental Medicine 2024-05-23
Coming Soon ...